MedTrace Logo

Effect of a Monthly High Dose of Vitamin D3 on Bariatric Surgery Patients

NCT02477956 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2015-06-23

No results posted yet for this study

Summary

Bariatric surgery patients tend to have malabsorption of many micronutrients such as B12, Iron and vitamin D postoperative. So in this study, a monthly high dose of vitamin D3 is giving to patients with their routine supplements and followed up for 6 months.

Hypothesis:Bariatric surgery subjects taking monthly high dose cholecalciferol supplements in addition to the standard vitamin D protocol will have a significant rise in serum vitamin D levels compared to the subjects taking only the usual vitamin D protocol.

Conditions

  • Morbid Obesity
  • Vitamin D Deficiency

Interventions

DIETARY_SUPPLEMENT

vitamin D3 (Replesta)

vitamin D group receive 2 replesta tablets (100,000 IU/month) of cholecalciferol.

DIETARY_SUPPLEMENT

vitamin D

Sponsors & Collaborators

  • Texas Tech University

    lead OTHER

Principal Investigators

  • David Syn, MD · Texas Tech University Health Sciences Center

  • Mallory Boylan, PhD · Texas Tech University

  • Hadil Subih, PhD · Texas Tech University

  • Shannon Owens, PhD · Texas Tech University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-11-30
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02477956 on ClinicalTrials.gov